April 6, 2020

LONGTIME DRUGBLOGGER DEREK LOWE isn’t enthusiastic about hydroxychloroquine.

Related: The Pandemic Pipeline. “Commercial biopharmaceutical discovery is a less than ideal vehicle for responding to an outbreak of a new viral pathogen spreading like wildfire through an immunologically naive population. Drug manufacturers are accustomed to navigating a regulatory and clinical development process that typically takes years, sometimes a decade or more; similarly, regulators have little experience for drug development in the context of a pandemic. There is no accelerated pathway for COVID-19 or any other emerging infectious disease.”

InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.